Eradication of biofilm-forming Staphylococcus epidermidis (RP62A) by a combination of sodium salicylate and vancomycin.

Antimicrob Agents Chemother

Department of Biochemistry, Microbiology and Molecular Genetics, University of Rhode Island, Kingston, Rhode Island 02881, USA.

Published: November 2001

Staphylococcus epidermidis is a major cause of infections associated with indwelling medical devices. Biofilm production is an important virulence attribute in the pathogenesis of device-related infections. Therefore, elimination of these biofilms is an ideal treatment. Salicylate (5 mM) combined with 1 microg of vancomycin per ml inhibited biofilm formation by S. epidermidis (RP62A) by >or=99.9%. When biofilm-coated polystyrene beads were exposed to 5 mM sodium salicylate and 4 microg of vancomycin per ml (one-half the minimum biofilm eradication concentration), there was a >99.9% reduction in viable count.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC90822PMC
http://dx.doi.org/10.1128/AAC.45.11.3262-3266.2001DOI Listing

Publication Analysis

Top Keywords

staphylococcus epidermidis
8
epidermidis rp62a
8
sodium salicylate
8
microg vancomycin
8
eradication biofilm-forming
4
biofilm-forming staphylococcus
4
rp62a combination
4
combination sodium
4
salicylate vancomycin
4
vancomycin staphylococcus
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!